LEXICON PHARMACEUTICALS, INC. (LXRX) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $447.00K; Additional Paid in CapitalUSD $2.23B; Treasury Stock, ValueUSD $2.84M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $4.00K; Common Stock, Value, IssuedUSD $426.00K; Additional Paid in CapitalUSD $2.22B; Treasury Stock, ValueUSD $2.84M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $366.00K; Additional Paid in CapitalUSD $2.13B; Treasury Stock, ValueUSD $5.19M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $366.00K; Additional Paid in CapitalUSD $2.13B; Treasury Stock, ValueUSD $5.19M.
LEXICON PHARMACEUTICALS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Treasury Stock, Preferred, Value USD | Treasury Stock, Carrying Basis USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $447.00K | $2.23B | $2.84M | $-204.00K | $-2.05B | $174.53M | $174.53M | 1.93M | (m) | 3 month · $3.34M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $4.00K | $426.00K | $2.22B | $2.84M | $-130.00K | $-2.02B | $202.86M | $202.86M | 1.93M | (m) | 3 month · $3.08M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $366.00K | $2.13B | $5.19M | $30.00K | $-2.02B | $107.54M | $107.54M | 2.38M | (m) | 12 month · $12.52M | 12 month · $0.00 | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $366.00K | $2.13B | $5.19M | $29.00K | $-2.00B | $120.16M | $120.16M | 2.38M | (m) | 3 month · $3.44M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $366.00K | $2.12B | $5.19M | $-14.00K | $-1.99B | $129.44M | $129.44M | 2.38M | (m) | 3 month · $3.19M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $366.00K | $2.12B | $5.19M | $25.00K | $-1.99B | $123.03M | $123.03M | 2.38M | (m) | 3 month · $3.04M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $363.00K | $2.12B | $4.62M | $119.00K | $-1.97B | $145.95M | $145.95M | 1.53M | 12 month · $1.73M | 12 month · $13.50M | 12 month · $0.00 | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $363.00K | $2.12B | $4.62M | $349.00K | $-1.93B | $178.51M | $178.51M | 1.53M | (m) | 3 month · $2.80M | 9 month · $0.00 | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $363.00K | $2.11B | $4.62M | $-193.00K | $-1.87B | $239.98M | $239.98M | 1.53M | (m) | 3 month · $4.86M | 6 month · $0.00 | (m) | (m) | (m) | (m) |
| 2024-03-31 | $23.00K | $248.00K | $2.11B | $4.62M | $-50.00K | $-1.82B | $288.87M | $288.87M | 1.53M | 3 month · $1.73M | 3 month · $4.30M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $245.00K | $1.86B | $2.88M | $31.00K | $-1.77B | $93.11M | $93.11M | 867.97K | 12 month · $824.00K | 12 month · $14.34M | 12 month · $307.00K | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $245.00K | $1.86B | $2.88M | $-113.00K | $-1.72B | $139.51M | $139.51M | 867.97K | (m) | 3 month · $3.90M | 9 month · $307.00K | (m) | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $245.00K | $1.86B | $2.88M | $-100.00K | $-1.67B | $186.36M | $186.36M | 867.97K | (m) | 3 month · $3.81M | 3 month · $307.00K 6 month · $307.00K | (m) | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $190.00K | $1.71B | $2.88M | $-163.00K | $-1.62B | $88.05M | $88.05M | (m) | 3 month · $824.00K | 3 month · $3.42M | (m) | (m) | (m) | (m) | 868.00K |
| 2022-12-31 | $0.00 | $189.00K | $1.71B | $2.06M | $-428.00K | $-1.59B | $117.12M | $117.12M | 488.20K | 12 month · $864.00K | 12 month · $11.52M | 3 month · $300.00K 12 month · $1.03M | $6.30M | $6.32M | (m) | 488.00K |
| 2022-09-30 | $0.00 | $189.00K | $1.71B | $2.06M | $-491.00K | $-1.56B | $144.02M | $144.02M | (m) | (m) | 3 month · $2.65M | 9 month · $698.00K | (m) | (m) | (m) | 488.00K |
| 2022-06-30 | $0.00 | $150.00K | $1.61B | $2.06M | $-150.00K | $-1.54B | $70.83M | $70.83M | (m) | (m) | 3 month · $2.83M | 6 month · $698.00K | (m) | (m) | (m) | 488.00K |
| 2022-03-31 | $0.00 | $150.00K | $1.61B | $2.06M | $-37.00K | $-1.51B | $92.70M | $92.70M | (m) | 3 month · $864.00K | 3 month · $2.77M | 3 month · $698.00K | (m) | $6.32K | (m) | 488.00K |
| 2021-12-31 | $0.00 | $150.00K | $1.61B | $7.52M | $-10.00K | $-1.49B | $113.59M | $113.59M | (m) | 12 month · $2.67M | 12 month · $10.58M | 12 month · $0.00 | (m) | (m) | (m) | 1.17M |
| 2021-09-30 | $0.00 | $150.00K | $1.61B | $7.52M | $-6.00K | $-1.46B | $136.60M | $136.60M | (m) | (m) | 3 month · $2.71M | 9 month · $0.00 | (m) | (m) | (m) | 1.17M |
| 2021-06-30 | $0.00 | $146.00K | $1.58B | $7.52M | $-5.00K | $-1.44B | $137.23M | $137.23M | (m) | (m) | 3 month · $2.79M | 6 month · $0.00 | (m) | (m) | 3 month · $31.00K | 1.17M |
| 2021-03-31 | $0.00 | $145.00K | $1.58B | $7.52M | $5.00K | $-1.42B | $152.55M | $152.55M | (m) | 3 month · $2.67M | 3 month · $2.85M | 3 month · $0.00 | (m) | (m) | (m) | 1.17M |
| 2020-12-31 | $0.00 | $142.00K | $1.56B | $4.84M | $-6.00K | $-1.40B | $156.37M | $156.37M | (m) | 12 month · $1.03M | 12 month · $13.27M | (m) | (m) | (m) | (m) | 793.00K |
| 2020-09-30 | $0.00 | $117.00K | $1.49B | $4.84M | $35.00K | $-1.39B | $87.64M | $87.64M | (m) | (m) | 3 month · $1.90M | (m) | (m) | (m) | (m) | 793.00K |
| 2020-06-30 | $0.00 | $108.00K | $1.47B | $4.84M | $312.00K | $-1.48B | $-10.69M | $-10.69M | (m) | 3 month · $103.00K | 3 month · $4.26M | (m) | (m) | (m) | (m) | 793.00K |
| 2020-03-31 | $0.00 | $108.00K | $1.47B | $4.74M | $860.00K | $-1.41B | $54.78M | $54.78M | (m) | 3 month · $923.00K | 3 month · $4.43M | (m) | (m) | (m) | (m) | 741.00K |
| 2019-12-31 | $0.00 | $106.00K | $1.46B | $3.82M | $84.00K | $-1.34B | $117.10M | $117.10M | (m) | 12 month · $941.00K | 12 month · $14.22M | (m) | (m) | (m) | (m) | 407.00K |
| 2019-09-30 | $0.00 | $106.00K | $1.46B | $3.82M | $36.00K | $-1.29B | $164.71M | $164.71M | (m) | (m) | 3 month · $3.56M | (m) | (m) | (m) | (m) | 407.00K |
| 2019-06-30 | $0.00 | $106.00K | $1.46B | $3.82M | $86.00K | $-1.52B | $-64.89M | $-64.89M | (m) | 6 month · $941.00K | 3 month · $3.77M 6 month · $3.41M | (m) | (m) | (m) | (m) | 407.00K |
| 2019-03-31 | $0.00 | $106.00K | $1.45B | $3.82M | $33.00K | $-1.49B | $-45.69M | $-45.69M | (m) | 3 month · $941.00K | 3 month · $3.41M | (m) | (m) | (m) | (m) | 407.00K |
| 2018-12-31 | $0.00 | $106.00K | $1.45B | $2.88M | $-12.00K | $-1.47B | $-26.41M | $-26.41M | (m) | 12 month · $972.00K | 12 month · $11.70M | (m) | (m) | (m) | (m) | 236.00K |
| 2018-09-30 | $0.00 | $106.00K | $1.44B | $2.88M | $-71.00K | $-1.47B | $-29.40M | $-12.71M | (m) | 9 month · $972.00K | 3 month · $2.88M 9 month · $8.85M | (m) | (m) | (m) | (m) | 236.00K |
| 2018-06-30 | $0.00 | $106.00K | $1.44B | $2.88M | $-218.00K | $-1.44B | $-5.07M | $11.50M | (m) | 6 month · $972.00K | 3 month · $2.90M 6 month · $5.97M | (m) | (m) | (m) | (m) | 236.00K |
| 2018-03-31 | $0.00 | $106.00K | $1.44B | $2.88M | $-394.00K | $-1.41B | $26.19M | $42.61M | (m) | 3 month · $972.00K | 3 month · $3.07M | (m) | (m) | (m) | (m) | 236.00K |
| 2017-12-31 | $0.00 | $106.00K | $1.44B | $1.90M | $-222.00K | $-1.37B | $68.27M | $68.27M | (m) | 12 month · $1.68M | 12 month · $9.47M | (m) | (m) | (m) | (m) | 122.00K |
| 2017-09-30 | $0.00 | $106.00K | $1.43B | $1.90M | $-63.00K | $-1.35B | $78.38M | $78.38M | (m) | 9 month · $1.68M | 9 month · $7.21M | (m) | (m) | (m) | (m) | 122.00K |
| 2017-06-30 | $0.00 | $105.00K | $1.43B | $1.90M | $-214.00K | $-1.32B | $106.31M | $106.31M | (m) | 6 month · $1.68M | 6 month · $4.63M | (m) | (m) | (m) | (m) | 122.00K |
| 2017-03-31 | $0.00 | $105.00K | $1.42B | $1.90M | $-264.00K | $-1.29B | $134.60M | $134.60M | (m) | 3 month · $1.68M | 3 month · $2.23M | (m) | (m) | (m) | (m) | 122.00K |
| 2016-12-31 | $0.00 | $105.00K | $1.41B | $3.37M | $-195.00K | $-1.25B | $167.51M | $157.40M | (m) | 12 month · $621.00K | 12 month · $7.45M | (m) | (m) | (m) | (m) | 306.00K |
| 2016-09-30 | $0.00 | $104.00K | $1.41B | $3.37M | $78.00K | $-1.22B | $185.18M | $185.18M | (m) | 9 month · $621.00K | 9 month · $5.72M | (m) | (m) | (m) | (m) | 306.00K |
| 2016-06-30 | $0.00 | $104.00K | $1.40B | $3.37M | $336.00K | $-1.18B | $217.33M | $217.33M | (m) | 6 month · $621.00K | 6 month · $3.79M | (m) | (m) | (m) | (m) | 306.00K |
| 2016-03-31 | $0.00 | $104.00K | $1.40B | $3.37M | $297.00K | $-1.14B | $252.88M | $252.88M | (m) | 3 month · $621.00K | 3 month · $1.83M | (m) | (m) | (m) | (m) | 306.00K |
| 2015-12-31 | $0.00 | $104.00K | $1.40B | $2.75M | $-219.00K | $-1.11B | $285.97M | $285.85M | (m) | 12 month · $357.00K | 12 month · $6.84M | (m) | (m) | (m) | (m) | 237.00K |
| 2015-09-30 | $0.00 | $104.00K | $1.40B | $2.75M | $58.00K | $-1.20B | $197.94M | $197.94M | (m) | 9 month · $357.00K | 9 month · $5.41M | (m) | (m) | (m) | (m) | 237.00K |
| 2015-06-30 | $0.00 | $104.00K | $1.39B | $2.75M | $98.00K | $-1.16B | $231.47M | $231.47M | (m) | 6 month · $357.00K | 6 month · $3.74M | (m) | (m) | (m) | (m) | 237.00K |
| 2015-03-31 | $0.00 | $727.00K | $1.39B | $2.75M | $23.00K | $-1.13B | $257.61M | $257.61M | (m) | 3 month · $357.00K | 3 month · $1.95M | (m) | (m) | (m) | (m) | 1.66M |
| 2014-12-31 | $0.00 | $104.00K | $1.39B | $2.39M | $-63.00K | $-1.10B | $284.02M | $284.02M | (m) | 12 month · $-887.00K | 12 month · $7.08M | (m) | (m) | (m) | (m) | 183.00K |
| 2014-09-30 | $0.00 | $516.00K | $1.18B | $2.39M | $2.00K | $-1.10B | $77.82M | $77.82M | (m) | 9 month · $887.00K | 9 month · $5.58M | (m) | (m) | (m) | (m) | 1.28M |
| 2014-06-30 | $0.00 | $516.00K | $1.18B | $2.39M | $5.00K | $-1.06B | $116.67M | $116.67M | (m) | 6 month · $887.00K | 6 month · $4.09M | (m) | (m) | (m) | (m) | 1.28M |
| 2014-03-31 | $0.00 | $516.00K | $1.18B | $2.39M | $10.00K | $-1.03B | $140.78M | $140.78M | (m) | 3 month · $887.00K | 3 month · $2.25M | (m) | (m) | (m) | (m) | 1.28M |
| 2013-12-31 | $0.00 | $514.00K | $1.18B | $1.50M | $2.00K | $-1.00B | $170.16M | $170.16M | (m) | 12 month · $-873.00K | 12 month · $7.42M | (m) | (m) | (m) | (m) | 814.00K |
| 2013-09-30 | $0.00 | $514.00K | $1.17B | $1.50M | $38.00K | $-986.54M | $185.71M | $185.71M | (m) | 9 month · $873.00K | 9 month · $5.73M | (m) | (m) | (m) | (m) | 814.00K |
| 2013-06-30 | $0.00 | $514.00K | $1.17B | $1.50M | $31.00K | $-954.89M | $215.08M | $215.08M | (m) | 6 month · $873.00K | 6 month · $3.98M | (m) | (m) | (m) | (m) | 814.00K |
| 2013-03-31 | $0.00 | $514.00K | $1.17B | $1.50M | $42.00K | $-925.81M | $242.21M | $242.21M | (m) | 3 month · $873.00K | 3 month · $2.11M | (m) | (m) | (m) | (m) | 814.00K |
| 2012-12-31 | $0.00 | $512.00K | $1.17B | $630.00K | $23.00K | $-899.83M | $266.68M | $266.68M | (m) | 12 month · $-285.00K | 12 month · $6.50M | (m) | (m) | (m) | (m) | 380.00K |
| 2012-09-30 | $0.00 | $495.00K | $1.13B | $630.00K | $21.00K | $-874.96M | $252.76M | $252.76M | (m) | 9 month · $285.00K | 9 month · $4.91M | (m) | (m) | (m) | (m) | 380.00K |
| 2012-06-30 | $0.00 | $481.00K | $1.09B | $630.00K | $-20.00K | $-845.42M | $244.90M | $244.90M | (m) | 6 month · $285.00K | 6 month · $3.31M | (m) | (m) | (m) | (m) | 380.00K |
| 2012-03-31 | $0.00 | $481.00K | $1.09B | $630.00K | $-57.00K | $-819.49M | $268.97M | $268.97M | (m) | 3 month · $285.00K | 3 month · $1.72M | (m) | (m) | (m) | (m) | 380.00K |
| 2011-12-31 | $0.00 | $480.00K | $1.09B | $345.00K | $21.00K | $-789.62M | $297.57M | $297.57M | (m) | 12 month · $-108.00K | 12 month · $5.71M | (m) | (m) | (m) | (m) | 218.00K |
| 2011-09-30 | $0.00 | $338.00K | $925.23M | $345.00K | $34.00K | $-755.78M | $169.48M | $169.48M | (m) | 9 month · $108.00K | 9 month · $4.35M | (m) | (m) | (m) | (m) | 218.00K |
| 2011-06-30 | $0.00 | $338.00K | $923.80M | $345.00K | $71.00K | $-729.67M | $194.19M | $194.19M | (m) | 6 month · $108.00K | 6 month · $2.92M | (m) | (m) | (m) | (m) | 218.00K |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $219.32M | (m) | 3 month · $-108.00K | 3 month · $1.47M | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $0.00 | $338.00K | $920.32M | $237.00K | $5.00K | $-673.41M | $247.02M | $247.02M | (m) | 12 month · $-149.00K | 12 month · $5.12M | (m) | (m) | (m) | (m) | 158.00K |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $268.85M | (m) | 9 month · $-149.00K | 9 month · $3.96M | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $295.04M | (m) | 6 month · $-149.00K | 6 month · $2.62M | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $163.50M | (m) | 12 month · $-88.00K | 12 month · $5.64M | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $195.83M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |